This next generation instrument brought the client’s breakthrough technology from the clinical lab to the point of care for life-saving results.

Breakthrough platform technology enables researchers to more effectively develop and automate new cell-based therapies.

An innovative robotic architecture delivers superior throughput for automated IHC & ISH staining and provides diagnosis up to 50 percent faster than previous generation stainers.

The first CLIA-waived Point of Care (POC) diagnostic device in eye care delivered improved performance and a better patient experience.

Complete manufacturing system delivered technology innovation, novel automation solutions, and substantial IP in the cell therapy manufacturing automation domain.

Next-generation fountain dispensers changed the game by delivering an unprecedented variety of beverage choices using technology initially developed for the medical industry.

Organovo turned science fiction into science fact with the world’s first commercial 3D bioprinter to print human tissues.

We provided turnkey instrument development and contract manufacture for a fully automated immunoassay instrument capable of up to 2200 results per hour.

Breakthrough manufacturing automation for cell expansion, formulation and working cell bank dispensing paves the way for treatment of debilitating illness.

Evolved existing technology into a highly usable, robust, market-ready general-purpose sample preparation instrument in just 20 months.

This facial cleansing brush redefined the market with breakthrough technology and a focus on user experience.

A revolutionary biomarker analysis platform realizing next-generation personalized healthcare.